valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

CENTRAL GARDEN & PET CO (CENT) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$30.00 ComplexityAverage Updated
$32.90 $81.34
bear $32.90 base $53.94 bull $81.34 margin of safety $30.00 market price* $42.04
Central Garden & Pet makes and distributes branded pet supplies (about $1.8 billion of sales: Nylabone chews, Kaytee bird and small-animal food, Aqueon aquatics, Adams and Zodiac flea and tick, Petmate carriers and bowls) and lawn and garden consumables (about $1.3 billion: Pennington grass seed, Amdro and Sevin pest controls, wild bird feed, fertilisers). Its strength is a portfolio of mid-sized category brands plus its own national distribution; its weakness is who buys them. Walmart is about 17% of sales, and Walmart, The Home Depot, Costco, Lowe's and Amazon together about 54%. In the garden business alone, Home Depot is about 37% and Walmart about 29%. A shelf-space decision by one of them can move a year's earnings. How we measure earnings. We start from operating cash flow, strip out swings in inventory and receivables, charge stock compensation as a real cost, and deduct the capital spending needed to keep the business running. This matters a great deal here: the company built about $256 million of inventory in fiscal 2022 and released it over 2023-2025, so raw cash flow swung from negative $34 million to positive $395 million while the underlying business barely changed. On a smoothed basis, owner earnings grew steadily from about $88 million in fiscal 2016 to $163 million in 2023, $200 million in 2024 and $218 million ($3.42 a share) in fiscal 2025. Non-cash items such as $28 million of facility-closure charges and $20 million of impairments in 2024 are added back; we treat the payments on store and warehouse leases as a real cost. Before its lenders, the business produced about $276 million in 2025, roughly $58 million of which went to bondholders as interest. The earnings level. We measure from fiscal 2022, after the 2021 Doskocil (Petmate) acquisition brought the business to its current $3.1-3.3 billion size. Over 2022-2025 the business generated a median of about $240 million a year before interest. The last two years ran higher ($258 million and $276 million) because a cost programme lifted gross margin 240 basis points to 31.9% and cut enterprise systems from 46 to six; the nine months to June 2026 held operating income flat at $256 million, which supports the improvement but does not prove it will last against shrinking sales. Revenue has fallen from $3.34 billion in 2022 to $3.13 billion in 2025, and nine-month sales in fiscal 2026 were $2.41 billion versus $2.45 billion a year earlier, despite about $58 million spent on acquisitions. Owner earnings grew about 9% in fiscal 2025; we assume no growth in year one because that improvement came from cost cuts, not sales, and sales are still declining. Debt. The company owes about $1.19 billion of fixed-rate notes: $300 million at 5.125% due February 2028, $500 million at 4.125% due October 2030 and $400 million at 4.125% due April 2031, with an undrawn asset-based credit line. It held about $1.0 billion of cash in June 2026. Allowing roughly $200 million of cash for the seasonal inventory build each spring, and crediting the benefit of borrowing below 6% for several more years, we count net debt at about $320 million. Cash on hand alone could repay the 2028 notes, so refinancing is not a pressing risk in any case. Base case: about $240 million a year before interest, flat for ten years, with volume declines offset by the cost savings already achieved, then fading about 1% a year as the brands keep their shelf space but are not growing. We credit no acquisition growth because the company's deals have recently replaced lost organic sales rather than added to them. The business is worth about $3.66 billion; after $320 million of net debt the shares are worth about $3.34 billion, or $53.94 each. Bear case: a repeat of the kind of downturn this company has actually had. In 2022-2024 retailer destocking and a grass-seed write-down cut operating income from $260 million to $185 million, almost 30%, and in fiscal 2013 a wet spring and lost garden shelf space nearly wiped out a year's profit. We model two years at about $165 million as a major retailer cuts inventory or moves a category to a rival or a store brand, partial recovery to $195 million, and then a 2% yearly decline as concentration keeps squeezing pricing. Even at the trough the business covers its interest more than three times. The business is worth about $2.36 billion; after net debt the shares are worth about $2.04 billion, or $32.90 each. Bull case: the higher 2025 level of about $275 million holds because the cost savings are structural, and the long-running habit of buying small brands and pushing them through Central's distribution adds about 2% a year, at or below the pace the company has sustained over two decades. The business is worth about $5.36 billion; after net debt, about $5.04 billion, or $81.34 a share. What would make this wrong: the loss of a major Walmart or Home Depot category (the largest single risk, and one no case fully captures); a further run of organic sales declines that the cost programme cannot offset; or an expensive acquisition bought at a high price and later written down, as has happened before with impairments in 2016, 2023 and 2024. Margin of safety price. We are reasonably confident in the earnings level: the business has produced positive owner earnings every year for a decade and the 2022-2025 period already includes a real destocking downturn. The worst plausible event is losing a large share of shelf space at Home Depot or Walmart; the balance sheet would survive it, since cash nearly covers all debt and nothing matures before 2028, but earnings could drop by a third for several years. If we are wrong about the cost savings lasting and about sales stabilising, the shares look worth roughly the bear figure in the low $30s. The company pays no dividend, so the return has to come from earnings, buybacks (about $155 million in fiscal 2025) and the price moving toward value, and the price assumes a three-to-four-year holding period. At $30 a share, the price is about ten times owner earnings after interest, the bear case implies roughly break-even, and if the base case plays out over three to four years it implies close to 20% a year. That is why we set the margin of safety price at $30. Our previous estimate counted the 2023-2025 inventory release as earnings; on the corrected measure, earnings are lower but steadier, the debt is smaller than the earnings it is set against, and the previous figures are not directly comparable.
Fiscal yearOwner's earningsMethodology
2025 $3.42 ▼
Recomputed on current basis (prior record did not remove working-capital release). FY ended Sep 27, 2025, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$332,506k; dWC (receivables 629, inventories 31,278, prepaid -2,740, AP 20,107, accrued 1,348, other LT obligations 986) = +$51,608k removed; SBC=$21,060k; capex=$41,418k, revenue declined 2.2% so growth capex=$0, maintenance capex=$41,418k; OE=$218,420k; diluted shares=63,815k; OE/sh=$3.42. Reconciliation (NI $163,963k + D&A + non-cash lease expense - lease payments + other non-cash - SBC - capex) ties. Source: FY2025 10-K, accession 0000887733-25-000041.
2024 $2.99 ▼
Recomputed on current basis (prior record did not remove the working-capital unwind). FY ended Sep 28, 2024, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$394,892k; dWC (receivables 11,857, inventories 84,306, prepaid 11,944, AP 18,373, accrued 17,152, other LT obligations -12,631) = +$131,001k removed; SBC=$20,583k; capex=$43,135k, revenue declined so growth capex=$0, maintenance capex=$43,135k; OE=$200,173k; diluted shares=66,860k; OE/sh=$2.99. Includes add-back of $27,842k facility-closure costs and $20,252k impairments (non-cash). Reconciliation ties. Source: FY2025 10-K, accession 0000887733-25-000041.
2023 $2.45 ▼
Recomputed on current basis (prior record did not remove the working-capital unwind). FY ended Sep 30, 2023, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$381,634k; dWC (receivables 43,980, inventories 86,980, prepaid 8,813, AP -19,962, accrued 6,766, other LT obligations 9,595) = +$136,172k removed; SBC=$27,990k; capex=$53,966k, revenue declined so growth capex=$0, maintenance capex=$53,966k; OE=$163,506k; diluted shares=66,783k (split-restated); OE/sh=$2.45. Reconciliation ties. Source: FY2025 10-K, accession 0000887733-25-000041.
2022 $2.26 ▼
Recomputed on current basis (prior record deducted total capex and did not remove the inventory build). FY ended Sep 24, 2022, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=-$34,030k; dWC (receivables 7,004, inventories -256,443, prepaid -6,031, AP -31,209, accrued -33,495, other LT obligations -7,728) = -$327,902k removed; SBC=$25,817k; capex=$115,205k, growth capex=1.85% x revenue increase $34,904k=$646k, maintenance capex=$114,559k; OE=$153,496k; diluted shares 54,425k x1.25 (January 2024 stock dividend restatement)=68,031k; OE/sh=$2.26. Reconciliation ties. Source: FY2022 10-K, accession 0000887733-22-000017.
2021 $2.35 ▼
Recomputed on current basis (prior record deducted total capex and did not remove working-capital swings). FY ended Sep 25, 2021, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$250,844k; dWC (receivables 69,135, inventories -132,170, prepaid 13,370, AP 24,583, accrued 6,734, other LT obligations 14,731) = -$3,617k removed; SBC=$23,127k; capex=$80,333k, growth capex=1.85% x revenue increase $608,175k=$11,250k, maintenance capex=$69,083k; OE=$162,251k; diluted shares 55,248k x1.25 (January 2024 stock dividend restatement)=69,060k; OE/sh=$2.35. Reconciliation (NI + non-cash charges - SBC - maintenance capex) ties. Source: FY2022 10-K, accession 0000887733-22-000017.
2020 $2.09 ▼
FY ended Sep 26, 2020, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$264,273k; dWC (receivables -91,470, inventories 27,351, prepaid 4,683, AP 52,047, accrued 72,278, other LT obligations -83) = +$64,806k removed; operating lease liability payments (-$36,089k) are kept in OE as a real occupancy cost, offsetting the non-cash lease expense add-back; SBC=$18,982k; capex=$43,055k, growth capex=1.85% x revenue increase $312,499k=$5,781k, maintenance capex=$37,274k; OE=$143,211k; diluted shares 54,738k x1.25 (January 2024 stock dividend restatement)=68,423k; OE/sh=$2.09. Reconciliation ties. Source: FY2020 10-K, accession 0000887733-20-000014.
2019 $1.72 ▼
FY ended Sep 28, 2019, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$204,974k; dWC (receivables 1,485, inventories -3,696, prepaid -2,643, AP 30,473, accrued 12,261, other LT obligations 306) = +$38,186k removed; SBC=$14,662k; capex=$31,577k, growth capex=1.85% x revenue increase $167,648k=$3,101k, maintenance capex=$28,476k; OE=$123,650k; diluted shares 57,611k x1.25 (January 2024 stock dividend restatement)=72,014k; OE/sh=$1.72. Reconciliation ties. Source: FY2020 10-K, accession 0000887733-20-000014.
2018 $2.03 ▼
FY ended Sep 29, 2018, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$114,112k; dWC (receivables -28,741, inventories -15,087, prepaid -3,803, AP -1,163, accrued -20,096, other LT obligations 1,053) = -$67,837k removed; SBC=$11,602k; capex=$37,845k, growth capex=1.85% x revenue increase $160,884k=$2,976k, maintenance capex=$34,869k; OE=$135,478k; diluted shares 53,341k x1.25 (January 2024 stock dividend restatement)=66,676k; OE/sh=$2.03. Reconciliation ties. Source: FY2020 10-K, accession 0000887733-20-000014.
2017 $1.48 ▼
FY ended Sep 30, 2017, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$114,309k; dWC (receivables -32,419, inventories -15,885, prepaid 2,845, AP -2,143, accrued 35,018, other LT obligations -889) = -$13,473k removed; SBC=$11,115k; excess tax benefits of $19,946k reclassified out of operating cash flow under pre-2017 rules added back; capex=$44,659k, growth capex=1.85% x revenue increase $225,461k=$4,171k, maintenance capex=$40,488k; OE=$96,125k; diluted shares 51,820k x1.25 (January 2024 stock dividend restatement)=64,775k; OE/sh=$1.48. Reconciliation ties. Source: FY2017 10-K, accession 0000887733-17-000014.
2016 $1.38 ▼
FY ended Sep 24, 2016, $ thousands. OE = CFO - dWC - SBC - maintenance capex. CFO=$151,426k; dWC (receivables 27,444, inventories -6,519, prepaid 6,901, AP -2,793, accrued 11,234, other LT obligations 1,083) = +$37,350k removed; SBC=$8,356k; excess tax benefits of $6,869k that were reclassified out of operating cash flow under pre-2017 rules are added back as cash tax savings; capex=$27,622k, capex/revenue mean 2016-2025 = 1.85%, revenue rose $178,280k so growth capex=$3,298k, maintenance capex=$24,324k; OE=$88,265k; diluted shares 51,075k x1.25 for the January 2024 one-for-four Class A stock dividend = 63,844k; OE/sh=$1.38. Reconciliation (NI $45,585k + non-cash charges - SBC - maintenance capex + tax benefit) ties exactly. Source: FY2017 10-K, accession 0000887733-17-000014.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (predominantly, across the Northeast, Midwest, West and South), sold largely through national retailers Walmart, The Home Depot, Costco, Lowe's and Amazon; minor sales in Canada and other international markets.
Historical growth strategy
Growth has come mainly from a long, steady record of acquiring branded pet and lawn-and-garden businesses (for example Nylabone, Aquascape, Doskocil/Petmate in 2021 and TDBBS in 2024) and selling them through its own distribution network into the large national retailers, with organic growth modest and recently negative; recent emphasis has shifted to cost reduction, plant consolidation and share repurchases.
Chart analysis
A chartist would describe Central Garden & Pet as a stock that spiked during the 2020-2021 pandemic surge in pet and gardening demand, then spent the following years in a broad sideways range well below that peak as sales normalised. The pattern reads as a long consolidation rather than a trend, with rallies repeatedly fading near the top of the range and support holding near the bottom; a technician would want to see a decisive breakout above the multi-year range on rising volume before calling a new uptrend, and would treat a break below range support as a sign the post-pandemic reset was not finished.
Competitors

Companies we consider competitors of CENT. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.